Regulation of gene expression in human cancers by TRIM24

Publication date: Available online 10 August 2016 Source:Drug Discovery Today: Technologies Author(s): Srikanth Appikonda, Kaushik N. Thakkar, Michelle Craig Barton Tripartite Motif-containing protein 24 (TRIM24) functions as an E3 ligase targeting p53 for ubiquitination, a histone ‘reader’ that interacts with a specific signature of histone post-translational modifications and a co-regulator of nuclear receptor-regulated transcription. Although mouse models of Trim24 depletion suggest that TRIM24 may be a liver-specific tumor suppressor, several studies show that human TRIM24 is an oncogene when aberrantly over expressed. This review focuses on the mechanisms of TRIM24 functions in oncogenesis and metabolic reprogramming, which underlie recent interest in therapeutic targeting of aberrant TRIM24 in human cancers.
Source: Drug Discovery Today: Technologies - Category: Drugs & Pharmacology Source Type: research